Bottom line
How much do GGHCX and JEHSX overlap?
59% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 48.2% of GGHCX's assets and 48.3% of JEHSX's. They share a meaningful core but differ in the rest of the portfolio.
JEHSX holds far more positions (173 vs 82), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings GGHCX and JEHSX have in common
| Holding | % of GGHCX | % of JEHSX | Overlap |
|---|---|---|---|
| Eli Lilly and Co. | 10.59% | 14.30% | 10.59% |
| Johnson & Johnson | 6.76% | 6.33% | 6.33% |
| UnitedHealth Group Inc. | 6.17% | 5.95% | 5.95% |
| Merck & Co., Inc. | 4.59% | 4.21% | 4.21% |
| AbbVie Inc. | 4.03% | 5.28% | 4.03% |
| Gilead Sciences, Inc. | 3.63% | 2.95% | 2.95% |
| CVS Health Corp. | 2.52% | 0.98% | 0.98% |
| BrightSpring Health Services, Inc. | 2.20% | 0.88% | 0.88% |
| Cardinal Health, Inc. | 2.10% | 1.09% | 1.09% |
| Guardant Health, Inc. | 2.04% | 1.28% | 1.28% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.38% | 2.01% |
| Thermo Fisher Scientific Inc. | 1.55% | 2.67% | 1.55% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- Royalty Pharma PLC — 2.13%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Only in JEHSX
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
- Intuitive Surgical Inc. — 1.98%
- Amgen Inc. — 1.90%
- Stryker Corporation — 1.87%
- Elevance Health Inc. — 1.63%
- Danaher Corporation — 1.51%
- Natera Inc. — 1.49%
- Royalty Pharma plc — 1.02%
- Tenet Healthcare Corporation — 0.99%
- Kymera Therapeutics Inc. — 0.93%
- Protagonist Therapeutics Inc. — 0.90%
- Moderna Inc. — 0.87%
Asset mix
| Asset type | GGHCX | JEHSX |
|---|---|---|
| Stocks | 97.5% | 99.0% |
| Cash & short-term funds | 8.8% | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | GGHCX | JEHSX |
|---|---|---|
| US | 93.5% | 95.0% |
| NL | 3.4% | 1.0% |
| GB | 3.1% | 0.8% |
| CH | 2.7% | 0.3% |
| BE | 1.2% | — |
| DK | 1.1% | 0.7% |
| IE | 0.6% | 0.9% |
| JP | — | 0.5% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do GGHCX and JEHSX overlap?
What stocks do GGHCX and JEHSX have in common?
Should I own both GGHCX and JEHSX?
Which holds more stocks, GGHCX or JEHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.